Treatment of Hormone Refractory Prostate Cancer with Quadramet and Taxotere
Treatment of Advanced Prostate Cancer
According to a press release from the Cytogen Corporation, treatment of advanced, hormone refractory prostate cancer with the chemotherapy drug Taxotere
Share this content.
If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.